Published in Obstet Gynecol on July 01, 2008
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab (2012) 2.25
Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause. Menopause (2013) 1.48
Bleeding patterns during the menopausal transition in the multi-ethnic Study of Women's Health Across the Nation (SWAN): a prospective cohort study. BJOG (2014) 1.40
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause (2012) 1.35
Menstrual bleeding patterns among regularly menstruating women. Am J Epidemiol (2012) 1.02
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril (2012) 1.01
Progesterone and ovulation across stages of the transition to menopause. Menopause (2009) 1.01
Menstruation and the menopausal transition. Obstet Gynecol Clin North Am (2011) 0.91
Reproductive hormones and the menopause transition. Obstet Gynecol Clin North Am (2011) 0.86
Hormone changes associated with the menopausal transition. Minerva Ginecol (2009) 0.84
Urinary 2/16 estrogen metabolite ratio levels in healthy women: a review of the literature. Mutat Res (2010) 0.79
Menstrual bleeding patterns: A community-based cross-sectional study among women aged 18-45 years in Southern Brazil. BMC Womens Health (2011) 0.78
Acute uterine bleeding unrelated to pregnancy: a Southern California Permanente Medical Group practice guideline. Perm J (2013) 0.75
Menstrual Cycle Hormone Changes in Women Traversing the Menopause: Study Of Women's Health Across the Nation. J Clin Endocrinol Metab (2017) 0.75
Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril (2001) 5.36
Hysterectomy rates in the United States 1990-1997. Obstet Gynecol (2002) 4.65
Variation of the human menstrual cycle through reproductive life. Int J Fertil (1970) 4.26
A microcolorimetric determination of creatine in urine by the Jaffe reaction. J Biol Chem (1954) 2.48
Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol (1994) 1.95
Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev (1998) 1.86
Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab (1996) 1.80
Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? Am J Obstet Gynecol (2004) 1.79
Menstrual cyclicity and the pre-menopause. Maturitas (1981) 1.63
Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol (2004) 1.61
Use of urine biomarkers to evaluate menstrual function in healthy premenopausal women. Am J Epidemiol (1998) 1.59
Menstrual patterns leading to the final menstrual period. Menopause (2002) 1.49
Assessing menstrual cycles with urinary hormone assays. Am J Physiol Endocrinol Metab (2002) 1.46
Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm. Environ Health Perspect (1996) 1.29
Using longitudinal data to define the perimenopause by menstrual cycle characteristics. Climacteric (1998) 1.12
The menopause transition: an update. Hum Reprod Update (2002) 0.85
Menstrual characteristics of 2,343 women attending the Shepherd Foundation. Aust N Z J Obstet Gynaecol (1979) 0.85
Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol (2009) 3.63
Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med (2014) 3.57
HIV infection and bone mineral density in middle-aged women. Clin Infect Dis (2006) 2.67
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48
Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab (2003) 2.47
Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab (2008) 2.27
Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod (2009) 2.26
Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife--SWAN, the study of women's health across the nation. Am J Obstet Gynecol (2008) 2.15
Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J (2005) 1.67
Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. N Engl J Med (2015) 1.65
Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures. Menopause (2012) 1.65
Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation. Menopause (2009) 1.64
Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril (2008) 1.64
Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol (2012) 1.62
Racial/ethnic differences in the prevalence of depressive symptoms among middle-aged women: The Study of Women's Health Across the Nation (SWAN). Am J Public Health (2004) 1.61
Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women. Menopause (2015) 1.61
Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol (1985) (2005) 1.60
Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition. Menopause (2011) 1.56
Follicle stimulating hormone and its rate of change in defining menopause transition stages. J Clin Endocrinol Metab (2008) 1.55
Adverse effects of induced hot flashes on objectively recorded and subjectively reported sleep: results of a gonadotropin-releasing hormone agonist experimental protocol. Menopause (2013) 1.54
Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns. Menopause (2008) 1.54
Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues (2005) 1.52
Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. Biochemistry (2010) 1.50
Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab (2007) 1.50
Body shape and size and insulin resistance as early clinical predictors of hyperandrogenic anovulation in ethnic minority adolescent girls. J Adolesc Health (2008) 1.47
The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab (2002) 1.47
Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care (2004) 1.45
Assessing comprehension of clinical research. Contemp Clin Trials (2011) 1.44
Hormones, mood, sexuality, and the menopausal transition. Fertil Steril (2002) 1.39
Consistent ovulation may not be enough to make women healthy when approaching menopause: an update from the Study of Women's Health Across the Nation. Menopause (2015) 1.39
Cardiovascular risk-factor knowledge and risk perception among HIV-infected adults. J Assoc Nurses AIDS Care (2013) 1.34
Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol (2013) 1.34
Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation. Menopause (2007) 1.34
Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab (2006) 1.30
Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab (2010) 1.29
Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol (2009) 1.29
Menopause symptoms in HIV-infected and drug-using women. Menopause (2005) 1.27
Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med (2006) 1.25
HIV infection, drug use, and onset of natural menopause. Clin Infect Dis (2005) 1.24
Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab (2012) 1.24
Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab (2009) 1.22
Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis (2005) 1.22
Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol (2007) 1.20
Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause (2006) 1.18
Cardiovascular risk factor variation within a Hispanic cohort: SWAN, the Study of Women's Health Across the Nation. Ethn Dis (2010) 1.16
Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN). J Clin Endocrinol Metab (2012) 1.15
The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemp Clin Trials (2012) 1.15
Menopausal symptoms and ethnicity: the Study of Women's Health Across the Nation. Womens Health (Lond Engl) (2009) 1.14
Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab (2006) 1.14
Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome. Hum Reprod (2010) 1.13
Overweight men: clinical pregnancy after ART is decreased in IVF but not in ICSI cycles. J Assist Reprod Genet (2010) 1.12
Classifying menopause stage by menstrual calendars and annual interviews: need for improved questionnaires. Menopause (2013) 1.10
Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab (2010) 1.09
Relationship of day-to-day reproductive hormone levels to sleep in midlife women. Arch Intern Med (2005) 1.08
Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation. Am J Epidemiol (2010) 1.08
Age-related decline in fertility. Endocrinol Metab Clin North Am (2003) 1.08
Risk factors for stress fracture among young female cross-country runners. Med Sci Sports Exerc (2007) 1.07
Recruitment challenges of a multicenter randomized controlled varicocelectomy trial. Fertil Steril (2011) 1.05
Endometrial thickness, Caucasian ethnicity, and age predict clinical pregnancy following fresh blastocyst embryo transfer: a retrospective cohort. Reprod Biol Endocrinol (2009) 1.04
Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause (2009) 1.04
Delayed symptoms of cerebrospinal fluid leak following lumbar decompression. Orthopedics (2008) 1.04
A new statistical approach demonstrated menstrual patterns during the menopausal transition did not vary by age at menopause. J Clin Epidemiol (2004) 1.03
Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, hispanic, and Asian/Pacific Islander women. Metabolism (2003) 1.03
Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs. Biol Chem (2011) 1.03
Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2014) 1.02
Partial recovery of luteal function after bariatric surgery in obese women. Fertil Steril (2008) 1.02
Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med (2011) 1.02
Physical functioning and menopause states. Obstet Gynecol (2007) 1.00
Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis (2011) 0.99
Longitudinal changes in hypothalamic and ovarian function in perimenopausal women with anovulatory cycles: relationship with vasomotor symptoms. Fertil Steril (2008) 0.99
Adiposity and hot flashes in midlife women: a modifying role of age. J Clin Endocrinol Metab (2011) 0.98
Vaginal pressure during lifting, floor exercises, jogging, and use of hydraulic exercise machines. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.98
Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in northern California. Cancer (2013) 0.97
Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev (2002) 0.95
Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition. J Bone Miner Res (2011) 0.95
A longitudinal investigation of coping strategies and quality of life among younger women with breast cancer. J Behav Med (2009) 0.95
The nucleolar channel system of human endometrium is related to endoplasmic reticulum and R-rings. Mol Biol Cell (2007) 0.95
"Persistence" improves the 60-day amenorrhea marker of entry to late-stage menopausal transition for women aged 40 to 44 years. Menopause (2010) 0.94
Chronic disease medication use in managed care and indemnity insurance plans. Health Serv Res (2003) 0.93
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93
Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis". Arch Intern Med (2008) 0.93
The menopausal transition: characteristics and management. Best Pract Res Clin Endocrinol Metab (2003) 0.92
Gestational angiogenic biomarker patterns in high risk preeclampsia groups. Am J Obstet Gynecol (2013) 0.92
Negative life events: risk to health-related quality of life in children and youth with HIV infection. J Assoc Nurses AIDS Care (2007) 0.91
Physical functioning among mid-life women: associations with trajectory of depressive symptoms. Soc Sci Med (2010) 0.90
Postthaw blastomere survival is predictive of the success of frozen-thawed embryo transfer cycles. Fertil Steril (2004) 0.89
Association of adolescent obesity and lifetime nulliparity--the Study of Women's Health Across the Nation (SWAN). Fertil Steril (2009) 0.89
The reproductive endocrinology of the menopausal transition. Steroids (2011) 0.89
Employment and caregiving: exploration of African American caregivers. Soc Work (2003) 0.89
Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women. Menopause (2008) 0.88
Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab (2014) 0.87
Nuclear pore complex proteins mark the implantation window in human endometrium. J Cell Sci (2008) 0.86
Dietary phytoestrogen intakes and cognitive function during the menopausal transition: results from the Study of Women's Health Across the Nation Phytoestrogen Study. Menopause (2012) 0.86
Sensitivity and specificity of recalled vasomotor symptoms in a multiethnic cohort. Am J Epidemiol (2008) 0.86
Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. Fertil Steril (2008) 0.86
Onset of ovulation after menarche in girls: a longitudinal study. J Clin Endocrinol Metab (2008) 0.86